MADISON, Wis.--(BUSINESS WIRE)--TomoTherapy Incorporated (NASDAQ: TOMO) announced today that the company held an EMEA (Europe, Middle East, Africa) User Symposium, May 15-17 in Antalya, Turkey. Representatives from 26 hospitals and clinics in nine countries attended the event where TomoTherapy formally introduced Jef Van Dam as General Manager of European Operations and established its EMEA Users Group, chaired by Professor Klaus Herfarth, M.D., Director of Radiation Oncology, University Clinic, Heidelberg, Germany.
